Position in OGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$40
+$23 QoQ
Shares Held
3
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#608
of 625 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fortis Group Advisors, LLC holds $10,238,680 across 11 Drug Manufacturers - General names. OGN ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,471 | $4,163,221 | |
| 2 | NVO |
Novo Nordisk A S
|
72,916 | $3,495,593 | |
| 3 | PFE |
Pfizer Inc
|
62,653 | $1,508,683 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,715 | $605,877 | |
| 5 | AMGN |
Amgen Inc
|
559 | $202,424 | |
| 6 | JNJ |
Johnson & Johnson
|
718 | $182,350 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
246 | $31,079 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
500 | $28,810 |
All Filings in OGN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40 | 3 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $17 | 3 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $21 | 3 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $32 | 3 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $29 | 3 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $44 | 3 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $44 | 3 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $57 | 3 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $62 | 3 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $56 | 3 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $86 | 6 | Shares | Sole | 2024-03-04 | |
| 2023-09-30 | $52 | 3 | Shares | Sole | 2023-12-01 | |
| No filing history on record for this holder in this stock. | ||||||